Senators Reintroduce Bill to Study Foreign Investment Impact on Pharmaceutical Supply Chains

Sens. Elizabeth Warren, D-Mass., and Marco Rubio, R-Fla., reintroduced a bill that would require the Federal Trade Commission, in consultation with the Commerce Department, to write a report on the effects of foreign investment in U.S. pharmaceutical supply chains. The senators said their bill would provide information that would help the U.S. reduce its dependence on potentially unreliable imports, including ingredients used in generic drugs. The United States Pharmaceutical Supply Chain Review Act was referred to the Senate Banking Committee.